AI Imaging Biomarkers for Oncology Clinical Trials | IAG and Picture Health Partnership
Image Analysis Group and Picture Health Partner to Advance AI-Driven Imaging Endpoints in Oncology Clinical Trials
AI Imaging Biomarkers in Oncology Clinical Trials
Image Analysis Group and Picture Health have formed a strategic partnership to accelerate oncology clinical trials by uniting IAG’s DYNAMIKA™ imaging platform with Picture Health’s multimodal AI biomarkers for precision oncology.
Cleveland, OH and London, UK – May 30, 2025 – Image Analysis Group (IAG), a globally recognized imaging clinical research organization (iCRO) known for its deep medical expertise and cutting edge AI-powered trial solutions, and Picture Health, a leader in AI imaging biomarkers to accelerate oncology clinical development, today announced a strategic partnership to enhance the development and adoption of advanced imaging technologies in clinical research trials.
Leadership Perspectives
“Partnering with Picture Health aligns perfectly with our mission to harness the power of AI and imaging for precision clinical trials,” said Dr. Olga Kubassova, President and CEO of Image Analysis Group (IAG). “By integrating our industry-leading platform DYNAMIKA™ with Picture Health’s impactful imaging biomarkers, we can deliver deeper insights and accelerate the development of life-changing oncology therapies.”
“At Picture Health, we’re transforming how imaging is used in clinical trials.” said Trishan Arul, Co-founder and CEO of Picture Health “Collaborating with IAG enables us to integrate our multimodal AI biomarkers with their expertise in clinical trial imaging, creating a seamless experience for our clients both in clinical and real-world settings.”
Partnership Scope and Impact
Together, the companies will provide life science organizations and healthcare providers with enhanced tools for early response detection, smarter patient stratification, and the prediction of oncology treatment outcomes.
- Seamless data management & hot transfers: IAG will enable robust collection of imaging data for further analysis by Picture Health.
- Actionable insights & analytics: Partner will enable bio-pharma clients to leverage AI and advanced imaging to improve early drug efficacy assessments in clinical trials. Enable more efficient handling and analysis of large-scale imaging data across multi-center studies.
- AI in Oncology Trials: This collaboration will combine IAG’s international expertise in planning, executing, and managing clinical trials that rely on traditional and AI-driven endpoints and its proprietary cloud-based platform, DYNAMIKA with Picture Health’s multimodal AI biomarkers that integrate advanced radiomics and pathomics to extract biologically interpretable, predictive insights from standard-of-care imaging using its Px™ Platform.
- Efficacy Evidence beyong RECIST: Support effective deployment of predictive analytics to ensure high-quality predictive data and lower investment risk and accelerate the timeline for bringing new therapies to market.
Event and Collaboration Opportunities
CEO Dr. Olga Kubassova at Image Analysis Group (IAG) will be available to discuss this collaboration, specifically AI-driven imaging in oncology trials during the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30–June 3, 2025, in Chicago, IL. To request a meeting or media interview with IAG, please contact our team in advance or visit the Image Analysis Group booth on-site.
About Picture Health
Picture Health is a precision oncology company that develops multimodal AI imaging biomarkers to transform routine medical images into actionable insights for cancer drug development and patient care. Its proprietary Px™ Platform integrates radiology, pathology, and clinical data to build biologically interpretable, predictive biomarkers that support smarter patient stratification, early response assessment, and more efficient oncology clinical trials for biopharma partners.
About Image Analysis Group (IAG)
Image Analysis Group (IAG) is a trusted partner to life sciences companies, combining deep expertise in medical imaging with the innovative power of its proprietary platform, DYNAMIKA™, to de-risk clinical development and accelerate the delivery of lifesaving therapies to patients. The IAG team designs and executes the imaging part of clinical trials that rely on radiological endpoints to demonstrate the safety and efficacy of new drug candidates. By using AI-powered endpoints and automating data management processes, with IAG you accelerate start-up and database lock, gain real-time visibility on trial progress, ensure clean data for regulatory submissions, and maximize patient recruitment speed. For nearly 20 years, the IAG team has helped reduce investment risk and accelerate study outcomes in over 700 trials, empowering biotech and pharmaceutical sponsors to make data-driven decisions with confidence.
You can read the full PR article here: Image Analysis Group and Picture Health Partner to Advance AI-Driven Imaging Endpoints in Oncology Clinical Trials
Media contact:
Marie Fussell
IAG Communications Lead
press@ia-grp.com
